Percutaneous repair or surgery for mitral regurgitation.

By A. Asgar, P. Khairy. 2011

771 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/01bad476295785acc1ecd186574e4784fb17c9e3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. (2013, methodology): “However, in an exploratory intention-to-treat analysis, surgery was nonsuperior in patients who were older than 70 years (p ¼ 0.009) and in patients with FMR, as compared with DMR (p ¼ 0.02).”
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017, background): “IIb B Transcatheter mitral valve repair may be considered for severely symptomatic patients (NYHA class III to IV) with chronic severe primary MR (stage D) who have favorable anatomy for the repair procedure and a reasonable life expectancy but who have a prohibitive surgical risk because of severe ”
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). (2012, unknown): “The applicability of the procedure is limited because precise echocardiographic criteria have to be respected to make a patient eligible.(136) Mitral valve repair has been reported after an unsuccessful clip procedure, although valve replacement may be necessary in up to 50% of such patients.”
[2017 ESC/EACTS Guidelines for the management of valvular heart disease]. (2017, background): “Among the transcatheter procedures, currently only the edge-to-edge mitral repair is widely adopted.(129) Experience with transcatheter annuloplasty, transapical chordal implantation or valve replacement is still limited and general recommendations cannot yet be made.”
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017, background): “IIb B Transcatheter mitral valve repair may be considered for severely symptomatic patients (NYHA class III to IV) with chronic severe primary MR (stage D) who have favorable anatomy for the repair procedure and a reasonable life expectancy but who have a prohibitive surgical risk because of severe ”